MadridActual – Hospital Gregorio Marañón Develops a Cell Therapy That Could Prevent Organ Transplant Rejection
Researchers at Hospital General Universitario Gregorio Marañón have developed a world-pioneering cell-based treatment to prevent organ transplant rejection. According to the Madrid-based team, the therapy may regulate the immune system’s response and prevent rejection. Developed over more than six years entirely at Gregorio Marañón, the treatment could completely inhibit or significantly reduce the immune response […]
EFE:Salud – Hospital Gregorio Marañón: A World-Pioneering Breakthrough to Prevent Transplant Rejection
Researchers at Hospital General Universitario Gregorio Marañón have fully developed a treatment unique worldwide based on cell therapy to prevent immune rejection and potentially extend the survival of transplanted organs indefinitely, thereby prolonging patients’ lives. The therapy and technology created by the hospital’s Immunoregulation Laboratory could establish a new paradigm in the treatment of multiple […]
El Mundo – A Baby Receives Cell Therapy for the First Time to Prevent Graft Rejection
If the technique proves effective over time, it could mark the beginning of a new era in the clinical management of transplant rejection. Six-month-old Irene has become the first of three children to receive a unique, cell-based therapy using regulatory T cells (Tregs) designed to control and reduce inappropriate inflammatory responses. The goal is to […]
El País – Irene, the First Transplanted Baby in the World to Receive a Cell Therapy Produced from an Organ Previously Discarded
A team at Gregorio Marañón has developed a therapy using regulatory T cells extracted from the thymus — located between the sternum and the heart — which was previously removed during heart transplant surgery and could offer a solution to transplant rejection. More info: elpais.com
